keyword
https://read.qxmd.com/read/38597438/-3-o-%C3%AE-chacotriosyl-glycyrrhetinic-acid-derivatives-as-potential-small-molecule-sars-cov-2-fusion-inhibitors-against-sars-cov-2-entry-into-host-cells
#21
JOURNAL ARTICLE
X Wan, C Hong, J Wang, G Song, S Liu
OBJECTIVE: To study the inhibitory activities of 3-O-β-chacotriosyl glycyrrhetinic acid derivatives against the entry of SARS-CoV-2 into host cells. METHODS: With pentacyclic triterpene saponin glycyrrhizic acid (a natural SARS-CoV-2 entry inhibitor) as the lead compound, a series of 3-O-β-chacotriosyl glycyrrhetinic acid derivatives were designed and synthesized based on hypridization principle, and their inhibitory activities against virus entry were tested in SARS-CoV-2 pseudovirusinfected cells...
March 20, 2024: Nan Fang Yi Ke da Xue Xue Bao, Journal of Southern Medical University
https://read.qxmd.com/read/38597260/tfe3-rearranged-pecoma-pecoma-like-neoplasms-report-of-25-new-cases-expanding-the-clinicopathologic-spectrum-and-highlighting-its-association-with-prior-exposure-to-chemotherapy
#22
JOURNAL ARTICLE
Pedram Argani, John M Gross, Ezra Baraban, Lisa M Rooper, Suping Chen, Ming-Tseh Lin, Christopher Gocke, Abbas Agaimy, Tamara Lotan, Albert J H Suurmeijer, Cristina R Antonescu
Since their original description as a distinctive neoplastic entity, ~50 TFE3-rearranged perivascular epithelioid cell tumors (PEComas) have been reported. We herein report 25 new TFE3-rearranged PEComas and review the published literature to further investigate their clinicopathologic spectrum. Notably, 5 of the 25 cases were associated with a prior history of chemotherapy treatment for cancer. This is in keeping with prior reports, based mainly on small case series, with overall 11% of TFE3-rearranged PEComas being diagnosed postchemotherapy...
April 10, 2024: American Journal of Surgical Pathology
https://read.qxmd.com/read/38596406/abemaciclib-and-vacuolin-1-decrease-aggregate-prone-tdp-43-accumulation-by-accelerating-autophagic-flux
#23
JOURNAL ARTICLE
Yoshinori Tanaka, Lina Kozuma, Hirotsugu Hino, Kosuke Takeya, Masumi Eto
(Macro)autophagy is a cellular degradation system for unnecessary materials, such as aggregate-prone TDP-43, a central molecule in neurodegenerative diseases including amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Abemaciclib (Abe) and vacuolin-1 (Vac) treatments are known to induce vacuoles characterized by an autophagosome and a lysosome component, suggesting that they facilitate autophagosome-lysosome fusion. However, it remains unknown whether Abe and Vac suppress the accumulation of aggregate-prone TDP-43 by accelerating autophagic flux...
July 2024: Biochemistry and Biophysics Reports
https://read.qxmd.com/read/38595815/case-report-egfr-fusion-mutation-combined-with-egfr-amplification-responds-to-egfr-tki-therapy
#24
Zhulin Wang, Chunyao Huang, Wenbo Fan, Shaowu Sun, Kaiyuan Li, Xu Liu, Jiangtao Pu, Guoqing Zhang, Xiangnan Li
Given their good antitumor effects, epidermal growth factor receptor ( EGFR ) tyrosine kinase inhibitors (TKIs) are standard first-line therapy for EGFR -sensitive mutations, including exon 19 deletions and exon 21 L858R mutations. EGFR fusion mutations and EGFR amplification are very rare in non-small cell lung cancer (NSCLC). We describe 2 patients with NSCLC harboring EGFR fusion mutations ( EGFR-MACF1 and EGFR-GNAT3 ) combined with EGFR amplification. Both patients received EGFR-TKI treatment, and 1 of them showed an antitumor response...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38589960/clinical-effects-of-atorvastatin-combined-with-conbercept-in-the-treatment-of-patients-with-macular-edema-secondary-to-retinal-vein-occlusion-and-carotid-plaque-study-protocol-for-a-prospective-randomized-controlled-trial
#25
JOURNAL ARTICLE
Bangtao Yao, Bei Wang, Jun Yang, Yan Geng, Hao Yu, Yuhui Liu, Gang Liu, Xiuying Wang
INTRODUCTION: Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) drugs have been widely used in patients with macular edema (ME) secondary to retinal vein occlusion (RVO); however, recurrence is a major concern. This study aims to observe the clinical effects of atorvastatin and intravitreal therapy in the treatment of patients with branch or central RVO-ME and coexistent carotid plaques (CP). METHODS AND ANALYSIS: A prospective randomized controlled clinical trial will be conducted...
April 8, 2024: Trials
https://read.qxmd.com/read/38588409/comprehensive-transcriptomic-analysis-of-ewsr1-wt1-targets-identifies-cdk4-6-inhibitors-as-an-effective-therapy-for-desmoplastic-small-round-cell-tumors
#26
JOURNAL ARTICLE
Justin W Magrath, Shruthi Sanjitha Sampath, Dane A Flinchum, Alifiani B Hartono, Ilon N Goldberg, Julia R Boehling, Suzana D Savkovic, Sean B Lee
UNLABELLED: Desmoplastic small round cell tumors (DSRCT) are a type of aggressive, pediatric sarcoma characterized by the EWSR1::WT1 fusion oncogene. Targeted therapies for DSRCT have not been developed, and standard multimodal therapy is insufficient, leading to a 5-year survival rate of only 15% to 25%. Here, we depleted EWSR1::WT1 in DSRCT and established its essentiality in vivo. Transcriptomic analysis revealed that EWSR1::WT1 induces unique transcriptional alterations compared with WT1 and other fusion oncoproteins and that EWSR1::WT1 binding directly mediates gene upregulation...
April 8, 2024: Cancer Research
https://read.qxmd.com/read/38585260/case-report-envafolimab-causes-local-skin-necrosis
#27
Jing Jing Liu, Xiao Ya Xu, Huan Han, Tong Wang, Wei Zhang, Jing Cui, Maksim Semenov
Envafolimab is a Chinese domestic innovative fusion of a humanized single-domain programmed death-ligand 1 (PD-L1) antibody (dAb) and human immunoglobulin IgG1 crystalline fragment (Fc) developed for subcutaneous injections. It was granted conditional market authorization by the China National Medical Product Administration (NMPA) in December 2021. Envafolimab is used to treat adult patients with previously treated microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) advanced solid tumors, including patients with advanced colorectal cancer disease progression who were previously administered fluorouracil, oxaliplatin, and irinotecan, as well as other patients with advanced solid tumors who experienced disease progression after receiving standard treatment and had no other alternative treatment options...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38584558/structural-basis-of-hiv-1-gp41-n-trimer-for-designing-bifunctional-peptide-based-fusion-inhibitors
#28
JOURNAL ARTICLE
Jinlin Wang, Peiying Li, Ruijuan Li, Guodong Liang, Yuheng Ma, Heiya Na
BACKGROUND: Pathogenic viruses that cause large-scale global or regional outbreaks almost always contain class I fusion proteins. Although the viruses differ in morphology, they all require fusion protein-mediated virus-host cell membranes during the early stages of host cell invasion. METHOD: The CHR region and NHR region of fusion proteins can form the 6-HB structure to drive the fusion pore formation between viruses and host cells through metastable interactions...
April 3, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38584068/etv6-ntrk2-fusion-in-a-patient-with-metastatic-pulmonary-atypical-carcinoid-successfully-treated-with-entrectinib-a-case-report-and-review-of-the-literature
#29
REVIEW
Wusheng Zhang, Sen Tian, Xiang Li, Yilin Chen, Xinyu Wang, Yunshuo Zhang, Lihui Lv, Yonghua Li, Hui Shi, Chong Bai
Pulmonary atypical carcinoid (AC) is an extremely rare neuroendocrine tumor. The neurotrophic tropomyosin receptor kinase (NTRK) fusions are reported in only 0.5% of nonsmall cell lung cancer, and are more rare in AC with only one previously reported case. Currently, there is little established evidence on the optimal therapeutic strategies and prognosis for advanced cases. We present a female patient with metastatic AC after complete resection. Due to low expression of somatostatin receptor in this case, somatostatin analogs and peptide receptor radionuclide therapy were not available...
March 19, 2024: Clinical Lung Cancer
https://read.qxmd.com/read/38581953/mdivi-1-effective-but-complex-mitochondrial-fission-inhibitor
#30
JOURNAL ARTICLE
Seor I Ahn, Sung Kyung Choi, Myoung Jun Kim, Jinhong Wie, Jueng Soo You
Mdivi-1, Mitochondrial DIVIsion inhibitor 1, has been widely employed in research under the assumption that it exclusively influences mitochondrial fusion, but effects other than mitochondrial dynamics have been underinvestigated. This paper provides transcriptome and DNA methylome-wide analysis for Mdivi-1 treated SH-SY5Y human neuroblastoma cells using RNA sequencing (RNA-seq) and methyl capture sequencing (MC-seq) methods. Gene ontology analysis of RNA sequences revealed that p53 transcriptional gene network and DNA replication initiation-related genes were significantly up and down-regulated, respectively, showing the correlation with the arrest cell cycle in the G1 phase...
April 3, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38578824/a-platform-for-predicting-mechanism-of-action-based-on-bacterial-transcriptional-responses-identifies-an-unusual-dna-gyrase-inhibitor
#31
JOURNAL ARTICLE
Shawn French, Amelia Bing Ya Guo, Michael J Ellis, Julia P Deisinger, Jarrod W Johnson, Kenneth Rachwalski, Zoë A Piquette, Telmah Lluka, Miranda Zary, Sineli Gamage, Jakob Magolan, Eric D Brown
In the search for much-needed new antibacterial chemical matter, a myriad of compounds have been reported in academic and pharmaceutical screening endeavors. Only a small fraction of these, however, are characterized with respect to mechanism of action (MOA). Here, we describe a pipeline that categorizes transcriptional responses to antibiotics and provides hypotheses for MOA. 3D-printed imaging hardware PFIboxes) profiles responses of Escherichia coli promoter-GFP fusions to more than 100 antibiotics. Notably, metergoline, a semi-synthetic ergot alkaloid, mimics a DNA replication inhibitor...
April 4, 2024: Cell Reports
https://read.qxmd.com/read/38575808/ltk-mutations-responsible-for-resistance-to-lorlatinib-in-non-small-cell-lung-cancer-harboring-clip1-ltk-fusion
#32
JOURNAL ARTICLE
Shunta Mori, Hiroki Izumi, Mitsugu Araki, Jie Liu, Yu Tanaka, Yosuke Kagawa, Yukari Sagae, Biao Ma, Yuta Isaka, Yoko Sasakura, Shogo Kumagai, Yuta Sakae, Kosuke Tanaka, Yuji Shibata, Hibiki Udagawa, Shingo Matsumoto, Kiyotaka Yoh, Yasushi Okuno, Koichi Goto, Susumu S Kobayashi
The CLIP1-LTK fusion was recently discovered as a novel oncogenic driver in non-small cell lung cancer (NSCLC). Lorlatinib, a third-generation ALK inhibitor, exhibited a dramatic clinical response in a NSCLC patient harboring CLIP1-LTK fusion. However, it is expected that acquired resistance will inevitably develop, particularly by LTK mutations, as observed in NSCLC induced by oncogenic tyrosine kinases treated with corresponding tyrosine kinase inhibitors (TKIs). In this study, we evaluate eight LTK mutations corresponding to ALK mutations that lead to on-target resistance to lorlatinib...
April 4, 2024: Communications Biology
https://read.qxmd.com/read/38573164/prevotella-timonensis-bacteria-associated-with-vaginal-dysbiosis-enhance-hiv-1-susceptibility-of-vaginal-cd4-t-cells
#33
JOURNAL ARTICLE
Nienke H van Teijlingen, Marleen Y van Smoorenburg, Ramin Sarrami-Forooshani, Esther M Zijlstra-Willems, John L van Hamme, Hanneke Borgdorff, Janneke Hhm van de Wijgert, Elisabeth van Leeuwen, Joris A M van der Post, Karin Strijbis, Carla M S Ribeiro, Teunis B H Geijtenbeek
Dysbiosis of the vaginal microbiome poses a serious risk for sexual HIV-1 transmission. Prevotella spp. are abundant during vaginal dysbiosis and associated with enhanced HIV-1 susceptibility; however, underlying mechanisms remain unclear. Here, we investigated the direct effect of vaginal bacteria on HIV-1 susceptibility of vaginal CD4+ T cells. Notably, pre-exposure to Prevotella timonensis enhanced HIV-1 uptake by vaginal T cells, leading to increased viral fusion and enhanced virus production. Pre-exposure to antiretroviral inhibitors abolished Prevotella timonensis-enhanced infection...
April 4, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38570119/study-of-the-antivirus-function-mediated-by-sting-in-micropterus-salmoides
#34
JOURNAL ARTICLE
Jin-Quan Fan, Qian-Ming Hong, Li-Shi Liu, Qi Chen, Yi-Hong Chen
Stimulator of interferon genes (STING) has been demonstrated as a critical mediator in the innate immune response to cytosolic DNA and RNA derived from different pathogens. While the role of Micropterus salmoides STING (MsSTING) in largemouth bass virus is still unknown. In this study, RT-qPCR assay and Western-blot assay showed that the expression levels of MsSTING and its downstream genes were up-regulated after LMBV infection. Pull down experiment proved that a small peptide called Fusion peptide (FP) that previously reported to target to marine and human STING as a selective inhibitor also interacted with MsSTING in vitro...
April 1, 2024: Fish & Shellfish Immunology
https://read.qxmd.com/read/38569862/-discontinuation-of-tyrosine-kinase-inhibitors-before-epiphyseal-closure-leading-to-improved-short-stature-in-pediatric-chronic-myelogenous-leukemia
#35
JOURNAL ARTICLE
Wataru Fukui, Taemi Ogura, Shohei Azumi, Hideto Ogata, Koji Kawaguchi, Takayuki Takachi, Yasuo Horikoshi, Ayumi Uematsu, Hiroyuki Shimada, Kenichiro Watanabe
A 3-year-old boy was referred to our hospital with splenomegaly. Blood tests revealed hyperleukocytosis and bone marrow examination showed major BCR::ABL1 fusion, leading to the diagnosis of chronic myelogenous leukemia (CML). Due to intolerance, the tyrosine kinase inhibitor (TKI) was changed from imatinib to dasatinib to nilotinib. The patient achieved molecular remission but became markedly short in stature, measuring 129.3 cm (height standard deviation score [SDS] -3.3) at the age of 12. TKI therapy was discontinued at age 12 years and 10 months, which was 9 years and 8 months after the start of TKI and 1 year and 6 months after achievement of MR4...
2024: [Rinshō Ketsueki] the Japanese Journal of Clinical Hematology
https://read.qxmd.com/read/38569029/recurrent-mutations-in-tumor-suppressor-fbxw7-bypass-wnt-%C3%AE-catenin-addiction-in-cancer
#36
JOURNAL ARTICLE
Zheng Zhong, David M Virshup
Pathologic Wnt/β-catenin signaling drives various cancers, leading to multiple approaches to drug this pathway. Appropriate patient selection can maximize success of these interventions. Wnt ligand addiction is a druggable vulnerability in RNF43 -mutant/ RSPO -fusion cancers. However, pharmacologically targeting the biogenesis of Wnt ligands, e.g., with PORCN inhibitors, has shown mixed therapeutic responses, possibly due to tumor heterogeneity. Here, we show that the tumor suppressor FBXW7 is frequently mutated in RNF43 -mutant/ RSPO -fusion tumors, and FBXW7 mutations cause intrinsic resistance to anti-Wnt therapies...
April 5, 2024: Science Advances
https://read.qxmd.com/read/38566638/bilateral-sudden-irreversible-hearing-loss-in-a-case-of-chronic-myeloid-leukaemia-a-case-report
#37
JOURNAL ARTICLE
Hafiz Malhan, Enas Dammag, Waiel Alkahiry, Gadallah Ali, Fahad Bahkali, Anas Alhakim, Mohammad Bakkar
Chronic myeloid leukemia is a type of blood cancer that affects the bone marrow and results in an overproduction of immature WBCs. The genetic mutation that causes CML is the BCR-ABL fusion gene. Adolescents are rarely affected. The case study aims to discuss a rare case of chronic myeloid leukemia causing bilateral hearing impairment, tinnitus, and vertigo. A 30-year-old female presented to the hospital in November, 2021, with sudden hearing impairment and other symptoms, leading to a CML diagnosis. Blood tests revealed hyperleukocytosis with marked neutrophilia, mild basophilia, and eosinophilia, and a BCR-ABL quantitation of 85%...
April 2024: Indian Journal of Otolaryngology and Head and Neck Surgery
https://read.qxmd.com/read/38566117/neq2x7-a-multi-purpose-and-open-source-fusion-dna-polymerase-for-advanced-dna-engineering-and-diagnostics-pcr
#38
JOURNAL ARTICLE
Cristina Hernández-Rollán, Anja K Ehrmann, Arsenios Vlassis, Vijayalakshmi Kandasamy, Morten H H Nørholm
Thermostable DNA polymerases, such as Taq isolated from the thermophilic bacterium Thermus aquaticus, enable one-pot exponential DNA amplification known as polymerase chain reaction (PCR). However, properties other than thermostability - such as fidelity, processivity, and compatibility with modified nucleotides - are important in contemporary molecular biology applications. Here, we describe the engineering and characterization of a fusion between a DNA polymerase identified in the marine archaea Nanoarchaeum equitans and a DNA binding domain from the thermophile Sulfolobus solfataricus...
April 2, 2024: BMC Biotechnology
https://read.qxmd.com/read/38565961/decreasing-mitochondrial-fission-ameliorates-hif-1%C3%AE-dependent-pathological-retinal-angiogenesis
#39
JOURNAL ARTICLE
Shu-Qi Huang, Kai-Xiang Cao, Cai-Ling Wang, Pei-Ling Chen, Yi-Xin Chen, Yu-Ting Zhang, Shi-Hui Yu, Zai-Xia Bai, Shuai Guo, Mu-Xi Liao, Qiao-Wen Li, Guo-Qi Zhang, Jun He, Yi-Ming Xu
Angiogenesis plays a critical role in many pathological processes, including irreversible blindness in eye diseases such as retinopathy of prematurity. Endothelial mitochondria are dynamic organelles that undergo constant fusion and fission and are critical signalling hubs that modulate angiogenesis by coordinating reactive oxygen species (ROS) production and calcium signalling and metabolism. In this study, we investigated the role of mitochondrial dynamics in pathological retinal angiogenesis. We showed that treatment with vascular endothelial growth factor (VEGF; 20 ng/ml) induced mitochondrial fission in HUVECs by promoting the phosphorylation of dynamin-related protein 1 (DRP1)...
April 2, 2024: Acta Pharmacologica Sinica
https://read.qxmd.com/read/38565504/-study-of-a-patient-with-myelodysplastic-myeloproliferative-neoplasm-with-co-morbid-neutrophilia-and-a-novel-ncor1-glyr1-fusion-gene
#40
JOURNAL ARTICLE
Yutian Lei, Xiaoli Zhao, Huihui Zhao, Yu Cheng, Shuai Wang, Jianyong Li, Yu Zhu
OBJECTIVE: To explore the genetic background for a patient with refractory myelodysplastic/myeloproliferative neoplasm (MDS/MPN) with co-morbid neutrophilia patient. METHODS: A MDS/MPN patient who was admitted to the First Affiliated Hospital of Nanjing Medical University in May 2021 was selected as the study subject. RNA sequencing was carried out to identify fusion genes in his peripheral blood mononuclear cells. Fusion gene sequence was searched through transcriptome-wide analysis with a STAR-fusion procedure...
April 10, 2024: Zhonghua Yi Xue Yi Chuan Xue za Zhi, Zhonghua Yixue Yichuanxue Zazhi, Chinese Journal of Medical Genetics
keyword
keyword
109238
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.